(BLRX) BioLineRx - Performance -88% in 12m
Compare BLRX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-92.11%
#181 in Group
Rel. Strength
1.81%
#7813 in Universe
Total Return 12m
-88.04%
#186 in Group
Total Return 5y
-95.30%
#144 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG 0.20
65th Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: BLRX (-88%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: BLRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BLRX
Total Return (including Dividends) | BLRX | XBI | S&P 500 |
---|---|---|---|
1 Month | 27.80% | 11.81% | 13.81% |
3 Months | -5.49% | -13.61% | -6.30% |
12 Months | -88.04% | -12.29% | 10.65% |
5 Years | -95.30% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | BLRX | XBI | S&P 500 |
1 Month | 85.4% | 72.9% | 83% |
3 Months | -50.6% | -83% | -75.3% |
12 Months | -92.5% | -51.6% | 50.1% |
5 Years | -81.0% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #77 | 14.3% | 12.3% |
3 Month | #47 | 9.40% | 0.86% |
12 Month | #187 | -86.4% | -89.2% |
5 Years | #146 | -93.8% | -97.7% |
FAQs
Does BLRX BioLineRx outperforms the market?
No,
over the last 12 months BLRX made -88.04%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months BLRX made -5.49%, while XBI made -13.61%.
Over the last 3 months BLRX made -5.49%, while XBI made -13.61%.
Performance Comparison BLRX vs Indeces and Sectors
BLRX vs. Indices BLRX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -9.28% | 14.0% | -77.3% | -98.7% |
US NASDAQ 100 | QQQ | -9.47% | 10.4% | -77.5% | -99.7% |
US Dow Jones Industrial 30 | DIA | -9.69% | 17.8% | -77.0% | -95.8% |
German DAX 40 | DAX | -9.26% | 12.8% | -104% | -114% |
Shanghai Shenzhen CSI 300 | CSI 300 | -11.5% | 16.0% | -78.1% | -95.4% |
Hongkong Hang Seng | HSI | -12.5% | 7.87% | -85.7% | -102% |
India NIFTY 50 | INDA | -4.36% | 23.0% | -77.8% | -87.8% |
Brasil Bovespa | EWZ | -10.3% | 10.6% | -86.0% | -79.7% |
BLRX vs. Sectors BLRX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -9.92% | 14.4% | -84.4% | -110% |
Consumer Discretionary | XLY | -9.66% | 13.6% | -76.3% | -102% |
Consumer Staples | XLP | -8.42% | 21.2% | -84.2% | -97.2% |
Energy | XLE | -9.10% | 21.0% | -70.7% | -78.6% |
Financial | XLF | -10.4% | 14.3% | -84.4% | -110% |
Health Care | XLV | -6.27% | 26.9% | -72.3% | -84.0% |
Industrial | XLI | -11.0% | 11.0% | -78.7% | -99.0% |
Materials | XLB | -9.08% | 14.2% | -72.4% | -82.8% |
Real Estate | XLRE | -7.96% | 16.3% | -78.1% | -103% |
Technology | XLK | -10.4% | 6.58% | -74.4% | -95.1% |
Utilities | XLU | -9.33% | 18.2% | -85.0% | -106% |
Aerospace & Defense | XAR | -11.3% | 6.64% | -88.8% | -115% |
Biotech | XBI | -2.69% | 16.0% | -57.2% | -75.8% |
Homebuilder | XHB | -9.75% | 16.3% | -64.1% | -80.5% |
Retail | XRT | -11.2% | 13.2% | -73.1% | -86.6% |